c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
IGC Pharma Completes CALMA Study Treatment Phase with 170 Participants (IGC)
GuruFocus | Nov 18, 2026 8:50 AM EST
Related Stocks: IGC ,
Read original article